Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 2
1985 1
1986 1
1988 2
1989 6
1990 5
1991 5
1992 6
1993 15
1994 12
1995 7
1996 6
1997 3
1998 5
1999 2
2000 5
2001 11
2002 11
2003 16
2004 34
2005 40
2006 41
2007 49
2008 83
2009 117
2010 94
2011 110
2012 144
2013 111
2014 119
2015 126
2016 153
2017 128
2018 141
2019 157
2020 180
2021 196
2022 188
2023 150
2024 91

Text availability

Article attribute

Article type

Publication date

Search Results

1,953 results

Results by year

Filters applied: . Clear all
Page 1
Metabolic syndrome, obesity and cancer risk.
Belladelli F, Montorsi F, Martini A. Belladelli F, et al. Among authors: montorsi f. Curr Opin Urol. 2022 Nov 1;32(6):594-597. doi: 10.1097/MOU.0000000000001041. Epub 2022 Sep 8. Curr Opin Urol. 2022. PMID: 36081396 Review.
Worldwide Temporal Trends in Penile Length: A Systematic Review and Meta-Analysis.
Belladelli F, Del Giudice F, Glover F, Mulloy E, Muncey W, Basran S, Fallara G, Pozzi E, Montorsi F, Salonia A, Eisenberg ML. Belladelli F, et al. Among authors: montorsi f. World J Mens Health. 2023 Oct;41(4):848-860. doi: 10.5534/wjmh.220203. Epub 2023 Feb 15. World J Mens Health. 2023. PMID: 36792094 Free PMC article.
Expression-based subtypes define pathologic response to neoadjuvant immune-checkpoint inhibitors in muscle-invasive bladder cancer.
Robertson AG, Meghani K, Cooley LF, McLaughlin KA, Fall LA, Yu Y, Castro MAA, Groeneveld CS, de Reyniès A, Nazarov VI, Tsvetkov VO, Choy B, Raggi D, Marandino L, Montorsi F, Powles T, Necchi A, Meeks JJ. Robertson AG, et al. Among authors: montorsi f. Nat Commun. 2023 Apr 27;14(1):2126. doi: 10.1038/s41467-023-37568-9. Nat Commun. 2023. PMID: 37105962 Free PMC article.
Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis.
Wenzel M, Nocera L, Collà Ruvolo C, Würnschimmel C, Tian Z, Shariat SF, Saad F, Tilki D, Graefen M, Kluth LA, Briganti A, Mandel P, Montorsi F, Chun FKH, Karakiewicz PI. Wenzel M, et al. Among authors: montorsi f. Prostate Cancer Prostatic Dis. 2022 Feb;25(2):139-148. doi: 10.1038/s41391-021-00395-4. Epub 2021 May 30. Prostate Cancer Prostatic Dis. 2022. PMID: 34054128 Free PMC article. Review.
Reply by Authors.
Martini A, Wever L, Soeterik TFW, Rakauskas A, Fankhauser CD, Grogg JB, Checcucci E, Amparore D, Haiquel L, Rodriguez-Sanchez L, Ploussard G, Qiang P, Affentranger A, Marquis A, Marra G, Ettala O, Zattoni F, Falagario UG, De Angelis M, Kesch C, Apfelbeck M, Al-Hammouri T, Kretschmer A, Kasivisvanathan V, Preisser F, Lefebvre E, Olivier J, Radtke JP, Briganti A, Montorsi F, Carrieri G, Moro FD, Boström P, Jambor I, Gontero P, Chiu PK, John H, Macek P, Porpiglia F, Hermanns T, van den Bergh RCN, van Basten JA, Gandaglia G, Valerio M. Martini A, et al. Among authors: montorsi f. J Urol. 2023 Jul;210(1):127. doi: 10.1097/JU.0000000000003442.02. Epub 2023 Apr 13. J Urol. 2023. PMID: 37052482 No abstract available.
Reply by Authors.
Pruthi DK, Miller G, Ankerst DP, Neumair M, Capitanio U, Correa AF, Lane BR, Roussel E, McGregor TB, Derweesh IH, Cordeiro M, Pierorazio PM, Calvo C, Bi H, Noyes SL, Meagher M, Kutikov A, Uzzo RG, Van Poppel H, Larcher A, Montorsi F, Kattan MW, Kaushik D, Liss MA. Pruthi DK, et al. Among authors: montorsi f. J Urol. 2023 Nov;210(5):761-762. doi: 10.1097/JU.0000000000003650.04. Epub 2023 Nov 1. J Urol. 2023. PMID: 37811759 No abstract available.
Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial.
Basile G, Bandini M, Gibb EA, Ross JS, Raggi D, Marandino L, Costa de Padua T, Crupi E, Colombo R, Colecchia M, Lucianò R, Nocera L, Moschini M, Briganti A, Montorsi F, Necchi A. Basile G, et al. Among authors: montorsi f. Clin Cancer Res. 2022 Dec 1;28(23):5107-5114. doi: 10.1158/1078-0432.CCR-22-2158. Clin Cancer Res. 2022. PMID: 36190522 Clinical Trial.
Reply by Authors.
Chakiryan NH, Dahmen A, Bandini M, Pederzoli F, Marandino L, Albersen M, Roussel E, Zhu Y, Ye DW, Ornellas AA, Catanzaro M, Hakenberg OW, Heidenreich A, Haidl F, Watkin N, Ager M, Chahoud J, Briganti A, Salvioni R, Montorsi F, Necchi A, Spiess PE. Chakiryan NH, et al. Among authors: montorsi f. J Urol. 2021 Oct;206(4):969. doi: 10.1097/JU.0000000000001790.02. Epub 2021 Aug 11. J Urol. 2021. PMID: 34379451 No abstract available.
1,953 results